adenosine has been researched along with rolofylline in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (57.14) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, A; Nonaka, H; Shimada, J; Suzuki, F | 1 |
| Karasawa, A; Kusaka, H | 1 |
| McGee, DS; Nakanishi, K; Tan, P; Vinten-Johansen, J; Zhao, ZQ | 1 |
| Karasawa, A; Mori, T; Moriyama, T | 1 |
| Karasawa, A; Kubo, K; Mizumoto, H | 1 |
| Ichimura, M; Kanda, T; Kase, H; Nonaka, H; Shimada, J; Suzuki, F; Takeda, M | 1 |
| Karasawa, A; Nagashima, K | 1 |
| Cheng, DY; DeWitt, BJ; Kadowitz, PJ; Neely, CF; Suzuki, F | 1 |
| Brause, M; Delabar, U; Eckardt, KU; Gleiter, CH; Zebski, H | 1 |
| Abe, Y; Aki, Y; Kimura, S; Kiyomoto, K; Nishiyama, A; Tomohiro, A | 1 |
| Iwao, H; Kim, S; Miura, K; Okumura, M; Yamanaka, S | 1 |
| Abe, Y; Aki, Y; Fukui, T; Kimura, S; Miyatake, A; Nishiyama, A; Rahman, M | 1 |
| El Nahas, AM; Fang, L; Haylor, JL; Morcos, SK; Oldroyd, SD; Yates, MS | 1 |
| Yao, K | 1 |
| Inscho, EW; Navar, LG; Nishiyama, A | 1 |
| Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Lambert, DG | 1 |
| Abe, Y; Aki, Y; Kimura, S; Kohno, M; Miyatake, A; Nishiyama, A | 1 |
| Abe, Y; Kimura, S; Li, FZ; Nishiyama, A; Rahman, M; Zhang, GX | 1 |
| Feng, MG; Navar, LG | 1 |
| Cronstein, BN; He, W; Mazumder, A; Wilder, T | 1 |
| Hsieh, CL; Huang, CP; Liao, HY; Lin, YW | 1 |
21 other study(ies) available for adenosine and rolofylline
| Article | Year |
|---|---|
8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Cell Membrane; Corpus Striatum; Guinea Pigs; Humans; Molecular Conformation; Molecular Structure; Prosencephalon; Purinergic Antagonists; Rats; Receptors, Purinergic; Stereoisomerism; Structure-Activity Relationship; Xanthines | 1992 |
Effects of repeated administration of KW-3902, a novel adenosine A1-receptor antagonist, on its pharmacological actions.
Topics: Acute Kidney Injury; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Administration, Oral; Animals; Diuretics; Furosemide; Glycerol; Heart Rate; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Trichlormethiazide; Urination; Xanthines | 1993 |
A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Animals; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Phenylisopropyladenosine; Rabbits; Random Allocation; Receptors, Adrenergic, alpha-1; Theophylline; Xanthines | 1994 |
Inhibitory effects of KW-3902, a selective adenosine A1-receptor antagonist, on the adenosine-induced shortening of action potential duration in guinea pig atrial muscles.
Topics: Action Potentials; Adenosine; Animals; Electrophysiology; Guinea Pigs; Heart Atria; Male; Purinergic P1 Receptor Antagonists; Xanthines | 1993 |
Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
Topics: Absorption; Acute Kidney Injury; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Blood Urea Nitrogen; Creatinine; Diuretics; Glycerol; GTP-Binding Proteins; Kidney; Kidney Tubules; Male; p-Aminohippuric Acid; Pertussis Toxin; Purinergic Antagonists; Rats; Rats, Wistar; Sensitivity and Specificity; Sodium; Virulence Factors, Bordetella; Water; Xanthines | 1993 |
KW-3902, a selective high affinity antagonist for adenosine A1 receptors.
Topics: Adenosine; Animals; Cyclic AMP; Diuretics; Dogs; Guinea Pigs; Ligands; Prosencephalon; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1996 |
Modulation of erythropoietin production by selective adenosine agonists and antagonists in normal and anemic rats.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Anemia; Animals; Erythropoietin; Hematocrit; Hypoxia; Kinetics; Male; Nephrectomy; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Time Factors; Xanthines | 1996 |
Adenosine A1 and A2 receptors mediate tone-dependent responses in feline pulmonary vascular bed.
Topics: Adamantane; Adenosine; Adenosine Triphosphate; Animals; Arginine; Cats; Female; Male; Methylene Blue; Morpholines; Muscle Tonus; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Xanthines | 1996 |
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Animals; Antihypertensive Agents; Carbon Monoxide; Dipyridamole; Diuretics; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Gene Expression; Hypoxia; Kidney; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Vasodilator Agents; Xanthines | 1997 |
Effects of KW-3902, a selective and potent adenosine A1 receptor antagonist, on renal hemodynamics and urine formation in anesthetized dogs.
Topics: Adenosine; Anesthesia; Animals; Diuretics; Dogs; Female; Furosemide; Hemodynamics; Kidney; Male; Purinergic P1 Receptor Antagonists; Urination; Vasoconstriction; Xanthines | 1997 |
No participation of adenosine A1 receptor in acute nephrotoxicity by 4-pentenoic acid administration in dogs.
Topics: Acute Kidney Injury; Adenosine; Animals; Diuretics; Dogs; Fatty Acids, Monounsaturated; Female; Glomerular Filtration Rate; Infusions, Intra-Arterial; Kidney; Male; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Xanthines | 1999 |
Adenosine A(1) receptor antagonist KW-3902 prevents hypoxia-induced renal vasoconstriction.
Topics: Adenosine; Anesthesia; Animals; Diuretics; Hypoxia; Kidney; Male; Microdialysis; Purinergic P1 Receptor Antagonists; Rabbits; Renal Circulation; Respiration, Artificial; Vasoconstriction; Xanthines | 1999 |
Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney.
Topics: Adenosine; Analysis of Variance; Animals; Contrast Media; Diatrizoate; Glomerular Filtration Rate; Kidney; Male; Perfusion; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Theophylline; Triiodobenzoic Acids; Xanthines | 2000 |
[Effect of KW-3902, a selective adenosine A1-receptor antagonist, on accumulation of gentamicin in the proximal renal tubules in rats].
Topics: Acute Kidney Injury; Adenosine; Animals; Anti-Bacterial Agents; Gentamicins; Kidney Tubules, Proximal; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Xanthines | 2000 |
Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity.
Topics: Adenosine; Animals; Arterioles; Extracellular Space; Male; Microcirculation; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Renal Circulation; Vasomotor System; Xanthines | 2001 |
Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed.
Topics: Adenosine; Adenosine Triphosphate; Animals; Cats; Dose-Response Relationship, Drug; Female; Hemodynamics; Hindlimb; Hyperemia; Male; Perfusion; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Triazoles; Vascular Resistance; Vasodilation; Xanthines | 2002 |
Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
Topics: Adenosine; Angiotensin II; Animals; Diuretics; Dogs; Dose-Response Relationship, Drug; Female; Infusions, Intra-Arterial; Male; Norepinephrine; Receptors, Purinergic P1; Renal Circulation; Vasoconstriction; Xanthines | 2002 |
Ischemic preconditioning protects post-ischemic renal function in anesthetized dogs: role of adenosine and adenine nucleotides.
Topics: Adenine; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Blood Pressure; Dogs; Ischemic Preconditioning; Kidney; Renal Circulation; Reperfusion Injury; Urine; Xanthines | 2005 |
Adenosine A2 receptor activation attenuates afferent arteriolar autoregulation during adenosine receptor saturation in rats.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Arterioles; Blood Pressure; Dose-Response Relationship, Drug; Homeostasis; Kidney; Male; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Adenosine A2; Theobromine; Vasoconstriction; Xanthines | 2007 |
Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma.
Topics: Acetamides; Adenosine; Aminopyridines; Animals; Bone and Bones; Cell Differentiation; Cells, Cultured; Dipyridamole; Female; Humans; Mice; Mice, Knockout; Multiple Myeloma; Osteocalcin; Osteoclasts; Purinergic P1 Receptor Agonists; Purines; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Reverse Transcriptase Polymerase Chain Reaction; Xanthines | 2013 |
Electroacupuncture Attenuates CFA-induced Inflammatory Pain by suppressing Nav1.8 through S100B, TRPV1, Opioid, and Adenosine Pathways in Mice.
Topics: Acupuncture Analgesia; Adenosine; Analgesics, Opioid; Animals; Behavior, Animal; Biomarkers; Chromones; Disease Models, Animal; Electroacupuncture; Freund's Adjuvant; Gene Deletion; Gene Expression; Gene Knockout Techniques; Glial Fibrillary Acidic Protein; Male; Mice; Morpholines; NAV1.8 Voltage-Gated Sodium Channel; Neurons; Pain; Pain Management; Proto-Oncogene Proteins c-akt; S100 Calcium Binding Protein beta Subunit; Signal Transduction; Spinal Cord Dorsal Horn; TOR Serine-Threonine Kinases; TRPV Cation Channels; Xanthines | 2017 |